Adjuvant Global Health Technology Fund, L.P. - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for AN2 Therapeutics, Inc. (ANTX)

Filing Manager
Adjuvant Global Health Technology Fund, L.P.
Reporting Manager
Adjuvant Capital GP, L.P.
Security
AN2 Therapeutics, Inc. Common Stock, $0.00001 par value per share
Symbol
ANTX
Shares outstanding
30M shares
Disclosed Ownership
2.37M shares
Ownership
7.9%
Form type
SCHEDULE 13G/A
Date filed
2/28/2025, 07:57 PM
Date of event
Dec 31, 2024
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Adjuvant Global Health Technology Fund, L.P. 6.7% 2M 0 2M /s/ Kabeer Aziz Vice President and Secretary of Adjuvant Capital Management, L.L.C., the sole general partner of Adjuvant Capital GP, L.P.
Adjuvant Global Health Technology Fund DE, L.P. 1.3% 378K 0 378K /s/ Kabeer Aziz Vice President and Secretary of Adjuvant Capital Management, L.L.C., the sole general partner of Adjuvant Capital GP, L.P.
Adjuvant Capital GP, L.P. 7.9% 2.37M 0 2.37M /s/ Kabeer Aziz Vice President and Secretary of Adjuvant Capital Management, L.L.C., the sole general partner of Adjuvant Capital GP, L.P.
Adjuvant Capital Management, L.L.C. 7.9% 2.37M 0 2.37M /s/ Kabeer Aziz Vice President and Secretary